Gao Z, Wang XY, Shen ZG, Liu JH, Wang XY, Wu SK, Jin X. Chemotherapy plus bevacizumab with or without anti-programmed death 1 immunotherapy as the second-line therapy in colorectal cancer. World J Gastroenterol 2025; 31(21): 106939 [PMID: 40538515 DOI: 10.3748/wjg.v31.i21.106939]
Please LOGIN to submit a new comment.